Biotech & pharma that raised money in Maryland
In the last 30 days, 6 biotech & pharma businesses in Maryland reported raising $72.1M on SEC Form D. The largest was Kaigene, Inc. ($55M), and Rockville led with 2 raises.
- New raises
- 11
- Capital reported
- $207M
- Median raise
- $5M
Aug 3, 2026 to Oct 16, 2026
sold to investors so far
among raises with sales
| Company | Location | Sector | Raised | Target | Filed |
|---|---|---|---|---|---|
| Kaigene, Inc. | Rockville, MD | Health Care | $55M | $73.3M | |
| Templar Nova, Inc. | Rockville, MD | Health Care | $7M | $7M | |
| Monocacy Therapeutics Inc. | Monrovia, MD | Health Care | $25K | $25K | |
| Seraxis Holdings, Inc. | Germantown, MD | Health Care | $10M | $10M | |
| Uvantis Therapeutics, Inc. | Columbia, MD | Health Care | $100K | $5M | |
| Monocacy Therapeutics Inc. | Monrovia, MD | Health Care | $49 | $49 | |
| Monocacy Therapeutics Inc. | Monrovia, MD | Health Care | $150K | $150K | |
| OS Therapies Inc | Grasonville, MD | Health Care | $5M | $10M | |
| Georgiamune, Inc. | Gaithersburg, MD | Health Care | $92.7M | $132M | |
| Cerium Pharmaceuticals, Inc. | Gaithersburg, MD | Health Care | $750K | $2.5M | |
| Theradaptive, Inc. | Frederick, MD | Health Care | $36.2M | $77.9M |
Biotech & pharma nationwide · All raises in Maryland · Filter these →